View More
Supported Portfolio Includes OCZ's Vector, Vertex, Agility
View More
Top 10 Most Recent News Articles
Navigating Roof Damage Insurance Claims: Key Insights
No one wants to deal with roof damage, but knowing the rules of the game is half the battle. The landscape of insurance claims can be tricky—especially when Mother Nature starts playing hard ball. Here, we break down what homeowners need to know to stay one step ahead in these situations. Unpacking Roof Damage Coverage Most homeowners think they've got things covered...
Continue ReadingDana-Farber Integrates IconPCR for Precise cfDNA Sequencing
Innovating Precision in cfDNA Sequencing One day you're trudging along old paths, and the next, technology throws you a curveball that's too critical to ignore. That's the scene at Dana-Farber Cancer Institute with their latest lab upgrade. They've bent the knee to integrate n6's iconPCR system into their toolkit for liquid biopsy research—a move that's caught my...
Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup
When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...
Continue Reading
Common ADHD Accommodations Fail to Boost Performance
Rethink ADHD Accommodations When it comes to ADHD, everyone ties the classic school accommodations to success. You give kids extra time, a quieter spot, and regular breaks, and you figure that's the magic formula, right? Well, hold onto your hats, because a fresh study out of Florida International University is flipping that script. Turns out, all those accommodations we...
Continue Reading
vVARDIS Debuts on NYSE: Transforming Dental Care
A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...
Continue Reading
NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos
Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...
Continue Reading
Dyania, NVIDIA Team Up: AI Transforming Patient Care
Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...
Continue Reading
Journalism Fights Back: Fourth Estate Awards 2026 Highlights
Imagine walking into a room where every whisper echoes the power of truth. That was the scene at the National Press Club's annual Fourth Estate Awards Gala, where the spotlight hit some of the most daring defenders of press freedom. These aren't just journalists by trade but warriors in the never-ending battle for transparency. Honoring the Relentless Pursuit of Truth The...
Continue Reading
Biointron's RushDATA™: Speeding Up Antibody Discovery
A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...
Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project
A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...
Continue ReadingTop 5 Most Recently Viewed Articles
Exciting New Indoor Adventure: Albatross to Open Soon
Albatross: A New Era in Indoor Entertainment Get ready for an unparalleled experience as Albatross prepares to open its doors, offering a unique blend of indoor mini putting, luxury bowling, craft cocktails, and vibrant dining options. This venue promises to redefine leisure and entertainment as we know it. Grand Opening Celebration Mark your calendars for the grand...
Continue Reading
Navigating Innovation: Key Insights from CIOs Worldwide
Understanding the Evolving Role of CIOs The 2025 CIO Report, released by Logicalis, offers invaluable insights gathered from the perspectives of over 1,000 CIOs across the globe. The report highlights a significant shift in the responsibilities of CIOs, revealing that 95% of organizations are making technological investments focused on generating new revenue streams...
Continue Reading
Jake Owen Set to Light Up NASCAR All-Star Race Weekend Concert
Exciting Concert Announcement for NASCAR All-Star Race Weekend As part of the thrilling NASCAR All-Star Race weekend, the multi-talented Jake Owen will take the stage on Saturday night as a centerpiece of the festivities. Presented by Raymer Oil, this special performance is eagerly anticipated by both race aficionados and country music fans alike. The event will be held...
Continue Reading
Keros Therapeutics Secures FDA Orphan Drug Designation for KER-065
Keros Therapeutics Secures FDA Orphan Drug Designation Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company based in Lexington, has made significant strides in the treatment landscape for Duchenne muscular dystrophy (DMD) by announcing that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for its promising candidate, KER-065....
Continue Reading
AM Best Upholds Credit Ratings for Partners Life Limited
AM Best Today Affirms Partners Life Limited's Credit Ratings Recently, AM Best provided a significant update, affirming the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) for Partners Life Limited. These ratings reflect a stable outlook for the company, underscoring its strong financial positioning in the insurance...
Continue Reading